Diamond Hill Capital Management
IRWD icon

Diamond Hill Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Diamond Hill Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-20,512
Closed -$273K – 157
2019
Q4 		$273K Hold
20,512
– – ﹤0.01% 150
2019
Q3 		$176K Buy
20,512
+10,000
+95% +$97.2K ﹤0.01% 160
2019
Q2 		$115K Buy
+10,512
New +$118K ﹤0.01% 165

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Diamond Hill Capital Management's IRWD Position: Q1 2020 in Review

Diamond Hill Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2020, closing a stake of 20,512 shares — an estimated $273K sold.

Diamond Hill Capital Management first reported a position in IRWD in Q2 2019 and held it in 3 quarters. The position peaked at $273K in Q4 2019. 193 funds tracked by Wall St. Rank hold IRWD as of Q1 2020.

  • Diamond Hill Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Diamond Hill Capital Management sold 20,512 Ironwood Pharmaceuticals shares in Q1 2020, an estimated $273K.
  • Diamond Hill Capital Management first reported a position in Ironwood Pharmaceuticals in Q2 2019 and held it in 3 quarters.
  • Diamond Hill Capital Management's Ironwood Pharmaceuticals position peaked at $273K in Q4 2019.
  • 193 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2020.

Based on Diamond Hill Capital Management's 13F filing for Q1 2020, filed 5 May 2020.